Eye Drop with Fas-Blocking Peptide Attenuates Age-Related Macular Degeneration

Eye Drop with Fas-Blocking Peptide Attenuates Age-Related Macular Degeneration

Age-related macular degeneration (AMD), characterized by macular retinal degeneration, poses a significant health concern due to the lack of effective treatments for prevalent dry AMD. The progression of AMD is closely linked to reactive oxygen species and Fas signaling, emphasizing the need for tar...

Full description

Bibliographic Details
Main Authors:	Yujong Yi, Seon-Hong Pyun, Chae-Yeon Kim, Gyeongju Yun, Eunhwa Kang, Seoyoun Heo, Irfan Ullah, Sang-Kyung Lee
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Series:	Cells
Subjects:	age-related macular degeneration (AMD) eye drops Fas-blocking peptide necrosis dry AMD wet AMD
Online Access:	https://www.mdpi.com/2073-4409/13/6/548

Similar Items

Experimental Models in Neovascular Age Related Macular Degeneration
by: Olivia Rastoin, et al.
Published: (2020-06-01)

A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration
by: Omar A. Halawa, et al.
Published: (2021-06-01)

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
by: Sonali Nashine
Published: (2021-09-01)

Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD)
by: Mayank Choubey, et al.
Published: (2023-11-01)

Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration
by: Hanan ElShelmani, et al.
Published: (2021-11-01)

Deep Learning Approach for Age-related Macular Degeneration Detection Using Retinal Images: Efficacy Evaluation of Different Deep Learning Models
by: Ngoc Thien Le, et al.
Published: (2023-12-01)

Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
by: Reem H. ElSheikh, et al.
Published: (2022-11-01)

Etiopathogenesis of non-exudative age-related macular degeneration (literature review)
by: M. M. Bikbov, et al.
Published: (2022-03-01)

Age-Related Macular Degeneration Staging by Color Fundus Photography vs. Multimodal Imaging—Epidemiological Implications (<i>The Coimbra Eye Study—Report 6</i>)
by: Cláudia Farinha, et al.
Published: (2020-05-01)

Severity of age-related macular degeneration at first presentation in Bhutan: a 3-year national study
by: Bhim B. Rai, et al.
Published: (2022-07-01)

Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration
by: Eleonora M. Lad, et al.
Published: (2023-09-01)

Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration
by: Treefa Shwani, et al.
Published: (2023-11-01)

Role of Optical Coherence Tomography Imaging in Predicting Progression of Age-Related Macular Disease: A Survey
by: Mohamed Elsharkawy, et al.
Published: (2021-12-01)

Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration
by: Avaylon J, et al.
Published: (2020-05-01)

Age-Related Macular Degeneration: Classification and Pathogenesis
by: İmren Akkoyun
Published: (2014-12-01)

Seven-year outcomes following intensive anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration
by: Regina Lukacs, et al.
Published: (2023-03-01)

Prevalence of insomnia and depression in patients with age-related macular degeneration
by: Elżbieta Nowak, et al.
Published: (2018-07-01)

Intravitreal Brolucizumab in Patients with Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
by: Ashwin Gupta, et al.
Published: (2022-01-01)

Early Stages of Age-Related Macular Degeneration: Racial/Ethnic Differences and Proposal of a New Classification Incorporating Emerging Concept of Choroidal Pathology
by: Mariko Sasaki, et al.
Published: (2022-10-01)

Abnormalities in the thickness of the retinal ganglion cell/inner plexiform layer in age-related macular degeneration
by: Živković Maja, et al.
Published: (2020-01-01)

Early and intermediate age-related macular degeneration: update and clinical review
by: García-Layana A, et al.
Published: (2017-10-01)

Dietary and Lifestyle Factors Modulate the Activity of the Endogenous Antioxidant System in Patients with Age-Related Macular Degeneration: Correlations with Disease Severity
by: Zofia Ulańczyk, et al.
Published: (2020-10-01)

Proteins Associated with Phagocytosis Alteration in Retinal Pigment Epithelial Cells Derived from Age-Related Macular Degeneration Patients
by: Audrey Voisin, et al.
Published: (2022-04-01)

The Role of Dysregulated miRNAs in the Pathogenesis, Diagnosis and Treatment of Age-Related Macular Degeneration
by: Karolina Urbańska, et al.
Published: (2022-07-01)

Dietary Patterns and Their Associations with Intermediate Age-Related Macular Degeneration in a Japanese Population
by: Mariko Sasaki, et al.
Published: (2022-03-01)

Zinc and Autophagy in Age-Related Macular Degeneration
by: Janusz Blasiak, et al.
Published: (2020-07-01)

Targeting Tissue Lipids in Age-related Macular Degeneration
by: Rajendra S. Apte
Published: (2016-03-01)

Management of wet AMD in an elderly patient - case report
by: Katarzyna Nowakowska, et al.
Published: (2021-08-01)

Prevalence of age-related macular degeneration in Iran and its projections through 2050: a systematic review and meta-analysis
by: Amirhossein Roshanshad, et al.
Published: (2023-11-01)

Safety and efficacy of Razumab™ (world’s first biosimilar ranibizumab) in wet age-related macular degeneration: a post-marketing, prospective ASSET study
by: Shashikant Sharma, et al.
Published: (2021-03-01)

OCT Angiography-based Evaluation of the Choriocapillaris in Neovascular Age-related Macular Degeneration
by: Varsha Pramil, et al.
Published: (2021-10-01)

Longitudinal Evaluation of Visual Function Impairments in Early and Intermediate Age-Related Macular Degeneration Patients
by: Eleonora M. Lad, MD, PhD, et al.
Published: (2022-09-01)

Treatment of age related macular degeneration (AMD) currently and in the past
by: Klaudia Brożyna, et al.
Published: (2018-08-01)

Treatment of age related macular degeneration (AMD) currently and in the past
by: Klaudia Brożyna, et al.
Published: (2018-08-01)

Long-term Outcomes of Treat and Extend Regimen of Anti-vascular Endothelial Growth Factor in Neovascular Age-related Macular Degeneration
by: Andy Lee, et al.
Published: (2020-08-01)

Understanding the Impact of Polyunsaturated Fatty Acids on Age-Related Macular Degeneration: A Review
by: Maëlis Brito, et al.
Published: (2024-04-01)

Plasma Metabolites Associated with OCT Features of Age-Related Macular Degeneration
by: Ines Lains, MD, PhD, et al.
Published: (2024-01-01)

Genome-wide association meta-analysis for early age-related macular degeneration highlights novel loci and insights for advanced disease
by: Thomas W. Winkler, et al.
Published: (2020-08-01)

Polymorphic nanobody crystals as long‐acting intravitreal therapy for wet age‐related macular degeneration
by: Shuqian Zhu, et al.
Published: (2023-11-01)

Investigation of novel combination therapy for age-related macular degeneration on ARPE-19 cells
by: Madhuri Dandamudi, et al.
Published: (2024-04-01)